Fixed Dose Combination of Empagliflozin and Linagliptin Tablets Price: A Comprehensive Guide.

Managing type 2 diabetes effectively often requires combination therapies that target different biological pathways to regulate blood glucose. One such potent option is the fixed dose combination of empagliflozin and linagliptin tablets. This blog delves into everything about this treatment option, including its uses, benefits, pricing details, and essential information to help you make an informed decision.

What is Empagliflozin and Linagliptin Fixed Dose Combination?

The fixed dose combination of empagliflozin and linagliptin tablets is a prescription medication designed to treat adults with type 2 diabetes mellitus. This combination uses two active ingredients that work synergistically to better control blood sugar levels:

• Empagliflozin: An SGLT2 (Sodium-Glucose Cotransporter-2) inhibitor that helps your kidneys remove excess glucose through urine, thereby lowering blood sugar.

• Linagliptin: A DPP-4 (Dipeptidyl Peptidase-4) inhibitor that increases insulin secretion and decreases glucagon levels in response to meals, thus enhancing glucose control.

Together, these two compounds provide a comprehensive approach to controlling blood glucose by improving insulin levels, reducing glucose production, and eliminating excess glucose via urination.

Empagliflozin and Linagliptin Tablets Uses

The primary uses of empagliflozin and linagliptin tablets are:

• To improve glycemic control in adults with type 2 diabetes mellitus whose blood sugar levels are not adequately controlled with diet, exercise, or monotherapy.

• To reduce the risk of cardiovascular death in adults with type 2 diabetes mellitus and established cardiovascular disease.

• As part of combination therapy when single or dual treatments have not achieved desired glucose level control.

By targeting multiple pathways, this medication helps maintain consistent blood sugar levels, reducing both fasting and postprandial (after meal) glucose spikes.

Benefits of Using Empagliflozin and Linagliptin Combination Therapy

• Dual Mechanism of Action: Empagliflozin increases glucose excretion, while linagliptin enhances insulin availability, resulting in better glycemic control.

• Cardiovascular Protection: Clinical trials (like EMPA-REG) show significant cardiovascular benefits, including reduced cardiovascular mortality.

• Convenience: The fixed dose format means only one tablet needs to be taken daily, improving medication adherence.

• Weight Control: Empagliflozin may help with weight reduction, a critical factor in managing type 2 diabetes.

• Low Risk of Hypoglycemia: When used as prescribed, the combination generally has a low risk of causing dangerously low blood sugar.

Empagliflozin and Linagliptin Tablets Price Overview

Understanding the empagliflozin and linagliptin tablets price is essential for patients to plan their treatment budget. Prices vary by brand, dosage, and regional factors.

• The market price for empagliflozin 25 mg and linagliptin 5 mg fixed dose tablets typically range from ₹15 to ₹22 per tablet in India, depending on the manufacturer. Brand names like Glyxambi and Ajaduo are available at different price points, e.g., Ajaduo priced around ₹20.78 per tablet by Lupin.

• Packs usually contain 10 tablets per strip or box, with prices from ₹150 to ₹800 for larger packaging and branded variants.

• The launch of generic versions following patent expiry has significantly lowered prices, making this combination more affordable without compromising quality.

Patients are advised to check with local pharmacies or online medical stores for the most current pricing and availability.

How to Use Empagliflozin and Linagliptin Tablets Safely

• These tablets are generally taken once daily, with or without food.

• Follow your doctor’s instructions precisely on dosage and timing.

• Monitor your blood glucose levels regularly to assess the effectiveness.

• Maintain a balanced diet and regular exercise routine alongside medication.

• Do not abruptly discontinue therapy without consulting your healthcare provider.

Important Precautions and Side Effects

Precautions:

• Not suitable for type 1 diabetes or diabetic ketoacidosis.

• Inform your doctor if you have kidney or liver disease before starting therapy.

• Avoid dehydration and maintain adequate fluid intake to prevent complications related to empagliflozin.

• Discuss other medications you are taking to avoid potential drug interactions.

Common Side Effects:

• Urinary tract infections (due to increased glucose in urine)

• Hypoglycemia (especially if combined with insulin or insulin secretagogues)

• Nasopharyngitis

• Increased urination and thirst

Rare but Serious:

• Ketoacidosis without high blood sugar

• Severe allergic reactions

• Kidney problems

Always report persistent or severe side effects to your healthcare provider immediately.

Empagliflozin and Linagliptin Tablets Uses in Diabetes Care

This combination is primarily prescribed to help:

• Control both fasting and post-meal blood sugar levels.

• Reduce cardiovascular risks linked to type 2 diabetes.

• Improve overall metabolic control as part of a comprehensive diabetes management plan that includes lifestyle changes.

It is increasingly recommended for patients needing enhanced glucose control with the added benefit of cardiovascular protection.

Why Choose Steris Healthcare For Empagliflozin and Linagliptin Tablets? 

Steris Healthcare is a trusted name in the Indian pharmaceutical landscape, known for delivering high-quality, effective, and affordable medicines. When it comes to Empagliflozin and Linagliptin Tablets, Steris Healthcare ensures superior manufacturing standards, using well-researched formulations that comply with global quality benchmarks. This combination of Empagliflozin and Linagliptin is widely used in the management of type 2 diabetes mellitus, helping to improve glycemic control in patients by combining two mechanisms of action—SGLT2 inhibition and DPP-4 inhibition. 

Choosing Steris Healthcare means opting for a product that’s backed by clinical expertise, manufactured in WHO-GMP certified facilities, and undergoes rigorous quality checks to ensure safety, stability, and efficacy. Moreover, Steris focuses on patient-centric care by offering this life-saving combination at a competitive price, making long-term diabetes management accessible to a wider population.